Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodica Pop-Busui

Showing results (261-270 of 277) with videos related to

Pageof 28
Sort By:
Diabetes Care|June 8, 2026
Please Tell Me It Is Only a Nightmare-The Proposed Dismantling of the United States Federal Research InfrastructureSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Journal of the American Heart Association|August 4, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Diabetes Care|December 22, 2022
"The Times They Are A-Changin'" at Diabetes CareSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
Diabetes Care|December 20, 2023
Reflecting on a Year at the Helm of Diabetes CareSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Pageof 28

Showing results (261-270 of 277) with videos related to

Sort By:
Pageof 28
Diabetes Care|June 8, 2026
Please Tell Me It Is Only a Nightmare-The Proposed Dismantling of the United States Federal Research InfrastructureSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Diabetes Technology & Therapeutics|March 16, 2022
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 DiabetesKellee M Miller, Lauren G Kanapka, Michael R Rickels, et al.
Journal of the American Heart Association|August 4, 2022
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19Shengyuan Luo, Alexi Vasbinder, Jeanne M Du-Fay-de-Lavallaz, et al.
Journal of Medical Virology|January 18, 2024
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19Alexi Vasbinder, Kishan Padalia, Ian Pizzo, et al.
Diabetes Technology & Therapeutics|December 6, 2022
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled TrialSatish K Garg, George Grunberger, Ruth Weinstock, et al.
Diabetes Care|December 22, 2022
"The Times They Are A-Changin'" at Diabetes CareSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
Diabetes Care|December 20, 2023
Reflecting on a Year at the Helm of Diabetes CareSteven E Kahn, Cheryl A M Anderson, John B Buse, et al.
Progress in Cardiovascular Diseases|May 13, 2023
Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology SocietyAndrea M Yeung, Jingtong Huang, Ambarish Pandey, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Pageof 28